Transplantation and Cellular Therapy

Published by: Elsevier Inc.  

People

  1. Giralt
    Giralt
  2. Perales
    Perales
  3. Dahi
    Dahi
  4. DeRespiris
    DeRespiris
  5. Jakubowski
    Jakubowski
  6. Lin
    Lin
  7. Papadopoulos
    Papadopoulos
  8. Scordo
    Scordo
  9. Shah
    Shah
  10. Chinapen
    Chinapen

Groups

  1. Bone Marrow Transplant (5)
  2. Center for Hematologic Malignancies (5)
  3. Clinical Pharmacy Specialists (5)
  4. Department of Medicine (5)
  5. Hematologic Malignancies, Division of (5)
  6. Biostatistics Service (4)
  7. CTCR Scholars (4)
  8. Epidemiology and Biostatistics (4)
  9. MSK Grad Students (4)
  10. Master of Science in Clinical and Translational Cancer Research (4)
Search Within
  1. "Andrew Lin"
Formats
  1. Journal Article (3)
  2. Meeting Abstract (2)
Groups
  1. Bone Marrow Transplant (5)
  2. Center for Hematologic Malignancies (5)
  3. Clinical Pharmacy Specialists (5)
  4. Department of Medicine (5)
  5. Hematologic Malignancies, Division of (5)
  6. Biostatistics Service (4)

More Groups

People
  1. Andrew Lin (5)
  2. Miguel-Angel Perales (4)
  3. Sean Devlin (4)
  4. Sergio Giralt (4)
  5. Ann Jakubowski (3)
  6. Esperanza Papadopoulos (3)

More People

Years
  1. 2024 (1)
  2. 2022 (3)
  3. 2021 (1)
Publishers
  1. Elsevier Inc. (5)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Reduced-intensity compared to nonmyeloablative conditioning in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic stem cell transplantation
    Journal Article

    Nath, K.; Peterson, K.; Brown, S.; Devlin, S.; Rodriguez, N.; Barker, J.; Giralt, S.; Gyurkocza, B.; Jakubowski, A.; Papadopoulos, E.; more...
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save
  • Evaluation of melphalan exposure in lymphoma patients undergoing BEAM and autologous hematopoietic cell transplantation
    Journal Article

    Dahi, P. B.; Lin, A.; Scordo, M.; Flynn, J. R.; Devlin, S. M.; Ruiz, J. D.; DeRespiris, L.; Carlow, D.; Cho, C.; Lahoud, O. B.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Daratumumab salvage therapy for refractory immune cytopenias after ALLOHCT
    Meeting Abstract

    Lin, A.; DeRespiris, L.; Chinapen, S.; Barker, J. N.; Castro-Malaspina, H.; Dahi, P. B.; Giralt, S. A.; Gyurkocza, B.; Jakubowski, A. A.; Lin, R. J.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Extended letermovir prophylaxis is highly effective cytomegalovirus (CMV) infection prevention in adult cord blood transplantation (CBT) recipients & does not prevent emergence of CMV-specific donor-derived immunity
    Meeting Abstract

    Politikos, I.; Lau, C.; Devlin, S. M.; Naputo, K.; Quach, S.; Chinapen, S.; Lin, A.; Papadopoulos, E. B.; Perales, M. A.; Shah, G.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Letermovir for prevention of cytomegalovirus reactivation in haploidentical and mismatched adult donor allogeneic hematopoietic cell transplantation with post-transplantation cyclophosphamide for graft-versus-host disease prophylaxis
    Journal Article

    Lin, A.; Flynn, J.; DeRespiris, L.; Figgins, B.; Griffin, M.; Lau, C.; Proli, A.; Devlin, S. M.; Cho, C.; Tamari, R.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save

    • Transplantation and Cellular Therapy – authorized name for:

    Name ISSN / ISBN Publisher
    Transplantation and Cellular Therapy 26666367 Elsevier Inc.
    Transplantation and Cellular Therapy 2666-6367 Elsevier Inc.
    Transplantation and Cellular Therapy 26666367 Unknown
    Transplantation and Cellular Therapy 26666375 Unknown
    Transplantation and Cellular Therapy 2666-6375 Elsevier Inc.
    Transplantation and Cellular Therapy 2666-6367 Elsevier Inc.
    Transplantation and Cellular Therapy 2666-6367 Elsevier Inc.
    Transplantation and Cellular Therapy 26666367 American Society for Transplantation and Cellular Therapy
    Transplantation and Cellular Therapy 26666367 2020
    Transplantation and Cellular Therapy 2666-6367 Elsevier Inc.
    Transplantation and Cellular Therapy 26666375 The American Society for Transplantation and Cellular Therapy
    Transplantation and Cellular Therapy 26666367 2021
    Transplantation and Cellular Therapy 26666375 2024
    Transplantation and Cellular Therapy 26666375 Elsevier B.V.
    Transplantation and Cellular Therapy 2666-6375 Elsevier Science, Inc.
    Transplantation and Cellular Therapy 2666-6375 Elsevier Science, Inc.
    Transplantation and Cellular Therapy 2666-6367 Elsevier Inc.
    Transplantation and Cellular Therapy 26666367 2023
    Transplantation and Cellular Therapy 26666375 The Authors
    Transplantation and Cellular Therapy 26666367 2022
    Transplantation and Cellular Therapy 26666367 The American Society for Transplantation and Cellular Therapy
    Transplantation and Cellular Therapy 26666367 Elsevier Inc.
    Transplantation and Cellular Therapy 26666367 2024
    Transplantation and Cellular Therapy 2666-6367 Elsevier Inc.
    Unknown (26666375) 26666375 Elsevier B.V.